Loading…
Axsome Therapeutics, Inc. is projected to rise to $306.14 by 2027, a +30% move from its current price of $234.64. AXSM is currently trading below its 50-day average (a bearish sign). Technical indicators currently lean sell.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 7/31/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Aug 1 | $229.80 | $234.84 | $239.99 | +0.09% |
| Aug 2 | $227.94 | $235.04 | $242.37 | +0.17% |
| Aug 3 | $226.57 | $235.25 | $244.26 | +0.26% |
| Aug 4 | $225.45 | $235.45 | $245.89 | +0.34% |
| Aug 5 | $224.49 | $235.65 | $247.37 | +0.43% |
| Aug 6 | $223.65 | $235.85 | $248.73 | +0.52% |
| Aug 7 | $222.89 | $236.06 | $250.00 | +0.60% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $222.89 | $236.06 | $250.00 | +0.60% |
| Week 2 | $218.97 | $237.48 | $257.57 | +1.21% |
| Week 3 | $216.31 | $238.92 | $263.89 | +1.82% |
| Week 4 | $214.29 | $240.36 | $269.60 | +2.44% |
| Week 5 | $212.68 | $241.81 | $274.93 | +3.06% |
| Week 6 | $211.36 | $243.27 | $280.00 | +3.68% |
| Week 7 | $210.26 | $244.74 | $284.89 | +4.31% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Axsome Therapeutics, Inc. is a biopharmaceutical company focused on developing and delivering novel therapies for central nervous system (CNS) disorders in the United States. Its commercial product portfolio includes Auvelity (dextromethorphan-bupropion), Sunosi (solriamfetol), and Symbravo (MoSEIC meloxicam rizatriptan), or AXS-07, indicated for the acute treatment of migraine, among other programs.
It also develops AXS-05 (dextromethorphan-bupropion) and other assets, with collaboration activities such as a Duke University research agreement evaluating AXS-05 in smoking cessation. The company was incorporated in 2012 and is based in New York, New York.
Axsome Therapeutics, Inc. trades under the ticker AXSM and has a current price of $233.80 with a market cap of $12.03B, ranking 824. The near-term outlook indicates neutrality for 2026, with a bullish path emerging in subsequent years. The year-by-year forecast shows a clear upward trajectory through 2030 and well beyond.
A major floor 33.4% below — a decisive break under it would weaken the trend.
The nearest floor, 5.5% below — buyers have tended to step in here.
The nearest ceiling, 7.5% above — a clean break opens room to run.
A major ceiling 13.6% above — clearing it would confirm fresh momentum.
Key AXSM support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of AXSM market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $235.13 | Sell | $234.08 | Buy |
| MA 10 | $234.54 | Buy | $235.18 | Sell |
| MA 20 | $237.42 | Sell | $236.60 | Sell |
| MA 50 | $238.77 | Sell | $232.36 | Buy |
| MA 100 | $211.56 | Buy | $216.92 | Buy |
| MA 200 | $184.73 | Buy | $191.30 | Buy |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 48.37 | Neutral |
| Stoch RSI (14) | 70.29 | Neutral |
| CCI (20) | -33.74 | Neutral |
| Williams %R (14) | -34.64 | Info |
| MACD (12,26,9) | -0.64 | Sell |
| ROC (12) | -0.26 | Sell |
| Bollinger %B (20,2) | 0.40 | Neutral |
| Stochastic %K (14) | 65.36 | Neutral |
| TRIX (15) | -0.06 | Sell |
| Awesome (5,34) | -6.01 | Sell |
| Ultimate (7,14,28) | 46.77 | Neutral |
| Momentum (10) | -2.40 | Sell |
| Aroon Osc (25) | -36.00 | Sell |
| Hull MA (9) | 231.76 | Buy |
| ADX (14) | 12.30 | Neutral |
| ATR (14) | 4.83 | Info |
The 30-day technical picture remains cautiously bullish overall. The RSI(14) is 40, with the SMA50 at $234.47 and the SMA200 at $176.66, suggesting upside potential above the short-term average. Key levels to watch are support at $222.16 and resistance at $255.17.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $154.12 | $234.64 | $322.20 | 0% | Neutral | |
| $248.69 | $306.14 | $395.46 | +30% | Bullish | |
| $284.95 | $358.56 | $477.64 | +53% | Bullish | |
| $353.92 | $453.45 | $618.75 | +93% | Bullish | |
| $411.00 | $534.96 | $744.92 | +128% | Bullish | |
| $511.41 | $675.24 | $957.10 | +188% | Bullish | |
| $622.56 | $832.96 | $1,199.64 | +255% | Bullish | |
| $674.73 | $914.01 | $1,335.58 | +290% | Bullish | |
| $736.78 | $1,009.82 | $1,495.41 | +330% | Bullish | |
| $796.28 | $1,103.61 | $1,654.72 | +370% | Bullish | |
| $1,421.45 | $2,071.23 | $3,272.39 | +783% | Bullish | |
| $2,850.69 | $4,518.18 | $7,709.97 | +18.3x | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| July 2026 | $154.12 | $234.64 | $273.51 | +0.00% |
| August 2026 | $209.25 | $244.53 | $291.63 | +4.22% |
| September 2026 | $215.75 | $253.79 | $305.94 | +3.79% |
| October 2026 | $214.93 | $254.17 | $309.00 | +0.15% |
| November 2026 | $214.51 | $254.78 | $311.88 | +0.24% |
| December 2026 | $219.36 | $261.58 | $322.20 | +2.67% |
Click any year to see its month-by-month AXSM forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
Expect AXSM to range from $154.12 to $322.20 through 2026. The $234.64 average target implies a 0% move from current prices. Price action looks broadly range-bound.
The AXSM price prediction for 2027 points to an average of $306.14 (low $248.69, high $395.46) — a potential gain of +30% on today's $234.64. Buyers look set to stay in control over this stretch.
In 2028, AXSM is projected to trade between $284.95 and $477.64, averaging $358.56 — a potential gain of +53% from today's $234.64. That is up +17% on the projected 2027 average. Momentum favours further upside here.
Axsome Therapeutics, Inc.'s 2029 outlook centres on $453.45, within a $353.92 to $618.75 range. That is up +26% on the projected 2028 average. That marks a +93% change versus current levels. Buyers look set to stay in control over this stretch.
By 2030, AXSM could reach as high as $744.92, with a base case around $534.96 and support toward $411.00 — roughly +128% from $234.64. Momentum favours further upside here.
Expect AXSM to range from $511.41 to $957.10 through 2031. The $675.24 average target implies a +188% move from current prices. That is up +26% on the projected 2030 average. Buyers look set to stay in control over this stretch.
The AXSM price prediction for 2032 points to an average of $832.96 (low $622.56, high $1,199.64) — a potential gain of +255% on today's $234.64. Momentum favours further upside here.
In 2033, AXSM is projected to trade between $674.73 and $1,335.58, averaging $914.01 — a potential gain of +290% from today's $234.64. That is up +10% on the projected 2032 average. Buyers look set to stay in control over this stretch.
Axsome Therapeutics, Inc.'s 2034 outlook centres on $1,009.82, within a $736.78 to $1,495.41 range. That is up +10% on the projected 2033 average. That marks a +330% change versus current levels. Momentum favours further upside here.
By 2035, AXSM could reach as high as $1,654.72, with a base case around $1,103.61 and support toward $796.28 — roughly +370% from $234.64. Buyers look set to stay in control over this stretch.
Expect AXSM to range from $1,421.45 to $3,272.39 through 2040. The $2,071.23 average target implies a +783% move from current prices. That is up +88% on the projected 2035 average. Momentum favours further upside here.
The AXSM price prediction for 2050 points to an average of $4,518.18 (low $2,850.69, high $7,709.97) — a potential gain of +18.3x on today's $234.64. Buyers look set to stay in control over this stretch.
Investing $1,000 in AXSM today (≈ 4.261848 AXSM) could be worth
$19,255.81
+$18,255.81 (+1826%) by 2050 · US Dollar
Based on the average projected AXSM price of $4,518.18 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in AXSMwould be worth at today's price.
$1,000 invested in AXSM on Jul 30, 2025 (≈ 9.875568 AXSM) would be worth
$2,317.2
+$1,317.2 (+131.7%) today · 2.32× · US Dollar
Based on a AXSM entry price of $101.26 vs. today's $234.64.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $241.53 | $971.47 | -2.9% |
| 1 month ago | $244.77 | $958.61 | -4.1% |
| 3 months ago | $206.53 | $1,136.11 | +13.6% |
| 6 months ago | $184.25 | $1,273.49 | +27.3% |
| 1 year ago | $101.26 | $2,317.2 | +131.7% |
| All time (5.0y) ago | $50.32 | $4,662.96 | +366.3% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our AXSM forecast.
Our base-case forecast reaches $470.00 around 2030.
Implied market cap at $470.00: $24.19B
Across the multi-year forecast, the expectation is for continued upside with rising average prices and sizable upside in later years. 2026 shows an average of $233.80 (neutral), then 2027 at $300.01 (ROI 28.3%), 2028 at $354.55 (ROI 51.6%), and 2029 at $439.36 (ROI 87.9%). By 2030 the average is $503.89 (ROI 115.5%), and 2035 reaches $1,028.80 (ROI 340), with a max outlook of $1,516.33.
The path continues to 2040 with an average of $1,903.64 (ROI 714.2%) and a 2050 average of $3,970.85 (ROI 1598.4%), all labeled bullish. These figures imply substantial upside over the long term, but they are estimates and not guarantees, and risks can vary with market conditions and execution milestones.
Tap a question to reveal the answer.
The 2030 forecast shows an average price of $503.89 with a min of $390.83 and a max of $693.22, and a projected ROI of 115.5% with a bullish sentiment.
The forecast turns bullish after 2026, with rising averages from 2030 onward (e.g., avg $503.89 in 2030, $1,903.64 in 2040, and $3,970.85 in 2050) and double- to triple-digit ROIs in later years, indicating strong upside potential but also noting the estimates are not guarantees.
Yes. The 2035 forecast shows an average price of $1,028.80 with a min of $753.78 and a max of $1,516.33, and a projected ROI of 340%.
For 2040, the forecast lists a min of $1,333.03, an average of $1,903.64, and a max of $2,946.81, with a ROI of 714.2% and a bullish sentiment.
The current price is $233.80 and the market cap is $12.03B, with a rank of 824.
Axsome Therapeutics, Inc. Community Discussion
0Share your Axsome Therapeutics, Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.